Australia is eagerly awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://kobihrds117059.wikigdia.com/8153673/this_new_drug_retatrutide_australia_a_promising_breakthrough_for_weight_management